Giovanni Targher

Verona, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 544 publications

Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023.

Global and regional projections of atherosclerotic cardiovascular-kidney-liver-metabolic disease burden to 2050: a forecasting analysis for the global burden of disease study 2023.

Journal: Metabolism: clinical and experimental

Published: June 22, 2026

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Association between visceral adiposity index and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes mellitus: an exploratory cross-sectional study.

Journal: Journal of endocrinological investigation

Published: June 16, 2026

Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications.

Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications.

Journal: Current obesity reports

Published: June 09, 2026

Semaglutide and Resmetirom in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: An Exploratory Indirect Comparison.

Semaglutide and Resmetirom in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: An Exploratory Indirect Comparison.

Journal: Diabetes, obesity & metabolism

Published: June 03, 2026

Dysregulated growth hormone-insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis.

Dysregulated growth hormone-insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: May 18, 2026

Sex- and menopause-specific inverse associations between metabolic dysfunction-associated steatotic liver disease and serum lipoprotein(a) concentrations: evidence from SHIP and UK Biobank.

Sex- and menopause-specific inverse associations between metabolic dysfunction-associated steatotic liver disease and serum lipoprotein(a) concentrations: evidence from SHIP and UK Biobank.

Journal: Cardiovascular diabetology

Published: April 10, 2026

Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta-Analysis.

Global Prevalence, Incidence, and Outcomes of Coexisting MASLD and Chronic Kidney Disease: A Meta-Analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 09, 2026

Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.

Journal: EXCLI journal

Published: April 03, 2026

Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023.

Burden and Regional Disparities of MASH-Related Liver Cancer in the Asia-Pacific Region From 1990 to 2023.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 30, 2026

Body composition in glucagon-like peptide-1 receptor agonist therapy: Absolute loss, relative changes, and outcomes.

Body composition in glucagon-like peptide-1 receptor agonist therapy: Absolute loss, relative changes, and outcomes.

Journal: Hepatology forum

Published: March 17, 2026

The privilege of serving as editor-in-chief of Nutrition, Metabolism and Cardiovascular Diseases.

The privilege of serving as editor-in-chief of Nutrition, Metabolism and Cardiovascular Diseases.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: March 10, 2026

Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study.

Trajectory of liver-related events following incident cardiovascular disease in MASLD: A 15-year population-based cohort study.

Journal: Metabolism: clinical and experimental

Published: March 10, 2026

Showing 1-12 of 544

Last Updated: 09/26/2026